CATH Search:   
       by CATH code, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: Alpha Beta (26913)
(-)
Architecture: 2-Layer Sandwich (8480)
(-)
Topology: Heat Shock Protein 90 (209)
(-)
Homologous Superfamily: [code=3.30.565.10, no name defined] (205)
(-)
Archaea (Sulfolobus shibatae) (1)
2ZBKB:14-229; D:14-229; F:14-229; H:14-229CRYSTAL STRUCTURE OF AN INTACT TYPE II DNA TOPOISOMERASE: INSIGHTS INTO DNA TRANSFER MECHANISMS
(-)
Baker's yeast (Saccharomyces cerevisiae) (27)
1A4HA:1-214STRUCTURE OF THE N-TERMINAL DOMAIN OF THE YEAST HSP90 CHAPERONE IN COMPLEX WITH GELDANAMYCIN
1AH6A:2-214STRUCTURE OF THE TETRAGONAL FORM OF THE N-TERMINAL DOMAIN OF THE YEAST HSP90 CHAPERONE
1AH8A:2-216; B:2-219STRUCTURE OF THE ORTHORHOMBIC FORM OF THE N-TERMINAL DOMAIN OF THE YEAST HSP90 CHAPERONE
1AM1A:2-214ATP BINDING SITE IN THE HSP90 MOLECULAR CHAPERONE
1AMWA:2-214ADP BINDING SITE IN THE HSP90 MOLECULAR CHAPERONE
1BGQA:1-214RADICICOL BOUND TO THE ATP BINDING SITE OF THE N-TERMINAL DOMAIN OF THE YEAST HSP90 CHAPERONE
1PVGA:15-258; B:15-258CRYSTAL STRUCTURE OF THE ATPASE REGION OF SACCHAROMYCES CEREVISIAE TOPOISOMERASE II
1QZRA:15-258; B:15-258CRYSTAL STRUCTURE OF THE ATPASE REGION OF SACCHAROMYCES CEREVISIAE TOPOISOMERASE II BOUND TO ICRF-187 (DEXRAZOXANE)
1US7A:2-208COMPLEX OF HSP90 AND P50
1ZW9A:2-214YEAST HSP82 IN COMPLEX WITH THE NOVEL HSP90 INHIBITOR 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE
1ZWHA:2-214YEAST HSP82 IN COMPLEX WITH THE NOVEL HSP90 INHIBITOR RADESTER AMINE
2AKPA:27-210; B:29-209HSP90 DELTA24-N210 MUTANT
2BRCA:1-214STRUCTURE OF A HSP90 INHIBITOR BOUND TO THE N-TERMINUS OF YEAST HSP90.
2BREA:2-214; B:2-219STRUCTURE OF A HSP90 INHIBITOR BOUND TO THE N-TERMINUS OF YEAST HSP90.
2CG9A:2-272; B:2-272CRYSTAL STRUCTURE OF AN HSP90-SBA1 CLOSED CHAPERONE COMPLEX
2FXSA:2-214YEAST HSP82 IN COMPLEX WITH THE NOVEL HSP90 INHIBITOR RADAMIDE
2IWSA:1-214RADICICOL ANALOGUES BOUND TO THE ATP SITE OF HSP90
2IWUA:1-214ANALOGUES OF RADICICOL BOUND TO THE ATP-BINDING SITE OF HSP90
2IWXA:1-214ANALOGUES OF RADICICOL BOUND TO THE ATP-BINDING SITE OF HSP90.
2VW5A:1-214; B:1-214; C:1-214; D:1-214STRUCTURE OF THE HSP90 INHIBITOR 7-O-CARBAMOYLPREMACBECIN BOUND TO THE N- TERMINUS OF YEAST HSP90
2VWCA:2-215STRUCTURE OF THE HSP90 INHIBITOR MACBECIN BOUND TO THE N-TERMINUS OF YEAST HSP90.
2WEPA:1-214YEAST HSP90 N-TERMINAL DOMAIN LI-IV MUTANT WITH ADP
2WEQA:2-214YEAST HSP90 N-TERMINAL DOMAIN LI-IV MUTANT WITH GELDANAMYCIN
2WERA:1-214; B:1-214YEAST HSP90 N-TERMINAL DOMAIN LI-IV MUTANT WITH RADICICOL
2XD6A:1-214HSP90 COMPLEXED WITH A RESORCYLIC ACID MACROLACTONE.
3C0EA:0-214YEAST HSP82 N-TERMINAL DOMAIN: EFFECTS OF MUTANTS 98-99 KS-AA
3C11A:1-214YEAST HSP82 N-TERMINAL DOMAIN-GELDANAMYCIN COMPLEX: EFFECTS OF MUTANTS 98-99 KS-AA
(-)
Bakers yeast (Saccharomyces cerevisiae) (1)
2CGFA:2-213A RADICICOL ANALOGUE BOUND TO THE ATP BINDING SITE OF THE N-TERMINAL DOMAIN OF THE YEAST HSP90 CHAPERONE
(-)
Barley (Hordeum vulgare) (1)
2JKIA:4-217; C:4-217; B:-5-217COMPLEX OF HSP90 N-TERMINAL AND SGT1 CS DOMAIN
(-)
Dog (Canis lupus familiaris) (22)
1QY5A:72-337CRYSTAL STRUCTURE OF THE N-DOMAIN OF THE ER HSP90 CHAPERONE GRP94 IN COMPLEX WITH THE SPECIFIC LIGAND NECA
1QY8A:72-337CRYSTAL STRUCTURE OF THE N-DOMAIN OF THE ER HSP90 CHAPERONE GRP94 IN COMPLEX WITH RADICICOL
1QYEA:72-337CRYSTAL STRUCTURE OF THE N-DOMAIN OF THE ER HSP90 CHAPERONE GRP94 IN COMPLEX WITH 2-CHLORODIDEOXYADENOSINE
1TBWB:79-337; A:76-337LIGAND INDUCED CONFORMATIONAL SHIFT IN THE N-TERMINAL DOMAIN OF GRP94, OPEN CONFORMATION
1TC0B:78-337; A:76-337LIGAND INDUCED CONFORMATIONAL SHIFTS IN THE N-TERMINAL DOMAIN OF GRP94, OPEN CONFORMATION COMPLEXED WITH THE PHYSIOLOGICAL PARTNER ATP
1TC6B:78-337; A:76-337LIGAND INDUCED CONFORMATIONAL SHIFT IN THE N-TERMINAL DOMAIN OF GRP94, OPEN CONFORMATION ADP-COMPLEX
1U0YA:73-337N-DOMAIN OF GRP94, WITH THE CHARGED DOMAIN, IN COMPLEX WITH THE NOVEL LIGAND N-PROPYL CARBOXYAMIDO ADENOSINE
1U0ZA:74-337; B:65-337N-DOMAIN OF GRP94 LACKING THE CHARGED DOMAIN IN COMPLEX WITH RADICICOL
1U2OA:65-337; B:65-337CRYSTAL STRUCTURE OF THE N-DOMAIN OF GRP94 LACKING THE CHARGED DOMAIN IN COMPLEX WITH NECA
1YSZA:74-337CRYSTAL STRUCTURE OF THE UNLIGANDED FORM OF GRP94, THE ER HSP90: BASIS FOR NUCLEOTIDE-INDUCED CONFORMATIONAL CHANGE, GRP94N(DELTA)41 APO CRYSTAL SOAKED WITH NECA
1YT0A:74-337CRYSTAL STRUCTURE OF THE UNLIGANDED FORM OF GRP94, THE ER HSP90: BASIS FOR NUCLEOTIDE-INDUCED CONFORMATIONAL CHANGE, GRP94N(DELTA)41 APO CRYSTAL SOAKED WITH ADP
1YT1A:65-337; B:65-337CRYSTAL STRUCTURE OF THE UNLIGANDED FORM OF GRP94, THE ER HSP90: BASIS FOR NUCLEOTIDE-INDUCED CONFORMATIONAL CHANGE, GRP94N(DELTA)41 APO CRYSTAL
1YT2A:73-337CRYSTAL STRUCTURE OF THE UNLIGANDED FORM OF GRP94, THE ER HSP90: BASIS FOR NUCLEOTIDE-INDUCED CONFORMATIONAL CHANGE, GRP94N APO CRYSTAL
2ESAA:74-337GRP94 N-TERMINAL DOMAIN BOUND TO GELDANAMYCIN: EFFECTS OF MUTANTS 168-169 KS-AA
2EXLB:73-337; A:72-337GRP94 N-TERMINAL DOMAIN BOUND TO GELDANAMYCIN
2FYPA:65-337; B:65-337GRP94 IN COMPLEX WITH THE NOVEL HSP90 INHIBITOR RADESTER AMINE
2GFDA:74-337; B:74-337GRP94 IN COMPLEX WITH THE NOVEL HSP90 INHIBITOR RADAMIDE
2GQPA:65-337; B:65-337N-DOMAIN OF GRP94 IN COMPLEX WITH THE NOVEL LIGAND N-PROPYL CARBOXYAMIDO ADENOSINE
2H8MB:74-337; A:74-337N-DOMAIN OF GRP94 IN COMPLEX WITH THE 2-IODO-NECA
2HCHB:65-337; A:65-337N-DOMAIN OF GRP94 IN COMPLEX WITH THE NOVEL LIGAND N-(2-AMINO)ETHYL CARBOXYAMIDO ADENOSINE
2HG1A:65-337; B:65-337N-DOMAIN OF GRP94 IN COMPLEX WITH THE NOVEL LIGAND N-(2-HYDROXYL)ETHYL CARBOXYAMIDO ADENOSINE
2O1WB:73-338; A:95-338; C:95-338; D:95-338; E:95-338STRUCTURE OF N-TERMINAL PLUS MIDDLE DOMAINS (N+M) OF GRP94
(-)
Escherichia coli bl21(de3). Organism_taxid: 469008. Strain: bl21-de3. (1)
1BXDA:290-450NMR STRUCTURE OF THE HISTIDINE KINASE DOMAIN OF THE E. COLI OSMOSENSOR ENVZ
(-)
Escherichia coli k12. Organism_taxid: 83333. Strain: k-12. (6)
1B62A:1-216MUTL COMPLEXED WITH ADP
1B63A:1-216MUTL COMPLEXED WITH ADPNP
1BKNA:20-216; B:420-616CRYSTAL STRUCTURE OF AN N-TERMINAL 40KD FRAGMENT OF E. COLI DNA MISMATCH REPAIR PROTEIN MUTL
1NHHA:1-216CRYSTAL STRUCTURE OF N-TERMINAL 40KD MUTL PROTEIN (LN40) COMPLEX WITH ADPNP AND ONE RUBIDIUM
1NHIA:1-216CRYSTAL STRUCTURE OF N-TERMINAL 40KD MUTL (LN40) COMPLEX WITH ADPNP AND ONE POTASSIUM
1NHJA:1-216CRYSTAL STRUCTURE OF N-TERMINAL 40KD MUTL/A100P MUTANT PROTEIN COMPLEX WITH ADPNP AND ONE SODIUM
(-)
Escherichia coli k12. Organism_taxid: 83333. Strain: k12. (1)
1R62A:194-349CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF THE TWO-COMPONENT SYSTEM TRANSMITTER PROTEIN NRII (NTRB)
(-)
Escherichia coli. Organism_taxid: 562. (9)
1AJ6A:12-217NOVOBIOCIN-RESISTANT MUTANT (R136H) OF THE N-TERMINAL 24 KDA FRAGMENT OF DNA GYRASE B COMPLEXED WITH NOVOBIOCIN AT 2.3 ANGSTROMS RESOLUTION
1S14B:2017-2217; A:1027-1217CRYSTAL STRUCTURE OF ESCHERICHIA COLI TOPOISOMERASE IV PARE 24KDA SUBUNIT
1S16A:1004-1215; B:2004-2215CRYSTAL STRUCTURE OF E. COLI TOPOISOMERASE IV PARE 43KDA SUBUNIT COMPLEXED WITH ADPNP
1Y4SA:1-229; B:1-229CONFORMATION REARRANGEMENT OF HEAT SHOCK PROTEIN 90 UPON ADP BINDING
1Y4UB:15-229; A:1-229CONFORMATION REARRANGEMENT OF HEAT SHOCK PROTEIN 90 UPON ADP BINDING
2IOPC:1-227; A:1-227; B:1-227; D:1-227CRYSTAL STRUCTURE OF FULL-LENGTH HTPG, THE ESCHERICHIA COLI HSP90, BOUND TO ADP
2IOQA:15-229; B:8-229CRYSTAL STRUCTURE OF FULL-LENGTH HTPG, THE ESCHERICHIA COLI HSP90
2IORA:0-211CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HTPG, THE ESCHERICHIA COLI HSP90, BOUND TO ADP
3G7EA:15-217CRYSTAL STRUCTURE OF E. COLI GYRASE B CO-COMPLEXED WITH PROP-2-YN-1-YL {[5-(4-PIPERIDIN-1-YL-2-PYRIDIN-3-YL-1,3-THIAZOL-5-YL)-1H-PYRAZOL-3-YL]METHYL}CARBAMATE INHIBITOR
(-)
Escherichia coli. Organism_taxid: 562. (3)
1EI1A:12-219; B:412-619DIMERIZATION OF E. COLI DNA GYRASE B PROVIDES A STRUCTURAL MECHANISM FOR ACTIVATING THE ATPASE CATALYTIC CENTER
1ID0A:335-480CRYSTAL STRUCTURE OF THE NUCLEOTIDE BOND CONFORMATION OF PHOQ KINASE DOMAIN
1KZNA:15-219CRYSTAL STRUCTURE OF E. COLI 24KDA DOMAIN IN COMPLEX WITH CLOROBIOCIN
(-)
Escherichia coli. Organism_taxid: 83333. Strain: k-12. (1)
3FV5B:15-215; A:15-215CRYSTAL STRUCTURE OF E. COLI TOPOISOMERASE IV CO-COMPLEXED WITH INHIBITOR
(-)
Geobacillus stearothermophilus. Organism_taxid: 1422. (5)
1L0OA:1-141; B:1-141CRYSTAL STRUCTURE OF THE BACILLUS STEAROTHERMOPHILUS ANTI-SIGMA FACTOR SPOIIAB WITH THE SPORULATION SIGMA FACTOR SIGMAF
1TH8A:1-139CRYSTAL STRUCTURES OF THE ADP AND ATP BOUND FORMS OF THE BACILLUS ANTI-SIGMA FACTOR SPOIIAB IN COMPLEX WITH THE ANTI-ANTI-SIGMA SPOIIAA: INHIBITORY COMPLEX WITH ADP, CRYSTAL FORM II
1THNA:2-137; C:2-137CRYSTAL STRUCTURES OF THE ADP AND ATP BOUND FORMS OF THE BACILLUS ANTI-SIGMA FACTOR SPOIIAB IN COMPLEX WITH THE ANTI-ANTI-SIGMA SPOIIAA: INHIBITORY COMPLEX WITH ADP, CRYSTAL FORM I
1TIDA:2-136; C:3-136CRYSTAL STRUCTURES OF THE ADP AND ATP BOUND FORMS OF THE BACILLUS ANTI-SIGMA FACTOR SPOIIAB IN COMPLEX WITH THE ANTI-ANTI-SIGMA SPOIIAA: POISED FOR PHOSPHORYLATION COMPLEX WITH ATP, CRYSTAL FORM I
1TILA:1-141; C:1-141; E:1-140CRYSTAL STRUCTURES OF THE ADP AND ATP BOUND FORMS OF THE BACILLUS ANTI-SIGMA FACTOR SPOIIAB IN COMPLEX WITH THE ANTI-ANTI-SIGMA SPOIIAA:POISED FOR PHOSPHORYLATION COMPLEX WITH ATP, CRYSTAL FORM II
(-)
Homo sapiens. Human (1)
3D0BA:16-223CRYSTAL STRUCTURE OF BENZAMIDE TETRAHYDRO-4H-CARBAZOL-4-ONE BOUND TO HSP90
(-)
Homo sapiens. Organism_taxid: 9606. (3)
3D2RA:190-374; B:190-374CRYSTAL STRUCTURE OF PYRUVATE DEHYDROGENASE KINASE ISOFORM 4 IN COMPLEX WITH ADP
3EKOA:10-226; B:9-226DIHYDROXYLPHENYL AMIDES AS INHIBITORS OF THE HSP90 MOLECULAR CHAPERONE
3EKRA:10-226; B:9-226DIHYDROXYLPHENYL AMIDES AS INHIBITORS OF THE HSP90 MOLECULAR CHAPERONE
(-)
Hordeum vulgare. Organism_taxid: 4513. (1)
2XCMA:-2-210; B:-2-210COMPLEX OF HSP90 N-TERMINAL, SGT1 CS AND RAR1 CHORD2 DOMAIN
(-)
Human (Homo sapiens) (95)
1BYQA:11-223HSP90 N-TERMINAL DOMAIN BOUND TO ADP-MG
1EA6A:27-231; B:27-231N-TERMINAL 40KDA FRAGMENT OF NHPMS2 COMPLEXED WITH ADP
1H7SA:29-231; B:33-231N-TERMINAL 40KDA FRAGMENT OF HUMAN PMS2
1H7UA:31-231; B:32-231HPMS2-ATPGS
1OSFA:9-223HUMAN HSP90 IN COMPLEX WITH 17-DESMETHOXY-17-N,N-DIMETHYLAMINOETHYLAMINO-GELDANAMYCIN
1UY6A:17-224HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(3,4,5-TRIMETHOXY-BENZYL)-9H-PURIN-6-YLAMINE
1UY7A:16-224HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(4-METHOXY-BENZYL)-9H-PURIN-6-YLAMINE
1UY8A:17-224HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(3-TRIMETHOXY-BENZYL)-9H-PURIN-6YLAMINE
1UY9A:16-224HUMAN HSP90-ALPHA WITH 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-PURIN-6-YLAMINE
1UYCA:16-224HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(2,5-DIMETHOXY-BENZYL)-9H-PURIN-6-YLAMINE
1UYDA:16-224HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(2-CHLORO-3,4,5-TRIMETHOXY-BENZYL)-9H-PURIN-6-YLAMINE
1UYEA:16-224HUMAN HSP90-ALPHA WITH 8-(2-CHLORO-3,4,5-TRIMETHOXY-BENZYL)-9-PENT-4-YLNYL-9H-PURIN-6-YLAMINE
1UYFA:16-224HUMAN HSP90-ALPHA WITH 8-(2-CHLORO-3,4,5-TRIMETHOXY-BENZYL)-2-FLUORO-9-PENT-4-YLNYL-9H-PURIN-6-YLAMINE
1UYGA:16-224HUMAN HSP90-ALPHA WITH 8-(2,5-DIMETHOXY-BENZYL)-2-FLUORO-9H-PURIN-6-YLAMINE
1UYHA:16-224HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(2,5-DIMETHOXY-BENZYL)-2-FLUORO-9H-PURIN-6-YLAMINE
1UYIA:16-224HUMAN HSP90-ALPHA WITH 8-(2,5-DIMETHOXY-BENZYL)-2-FLUORO-9-PENT-9H-PURIN-6-YLAMINE
1UYKA:16-224HUMAN HSP90-ALPHA WITH 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-2-FLUORO-9H-PURIN-6-YLAMINE
1UYLA:17-224STRUCTURE-ACTIVITY RELATIONSHIPS IN PURINE-BASED INHIBITOR BINDING TO HSP90 ISOFORMS
1UYMA:16-226HUMAN HSP90-BETA WITH PU3 (9-BUTYL-8(3,4,5-TRIMETHOXY-BENZYL)-9H-PURIN-6-YLAMINE)
1Y8NA:184-368CRYSTAL STRUCTURE OF THE PDK3-L2 COMPLEX
1Y8OA:184-368CRYSTAL STRUCTURE OF THE PDK3-L2 COMPLEX
1Y8PA:184-368CRYSTAL STRUCTURE OF THE PDK3-L2 COMPLEX
1YC1A:15-224CRYSTAL STRUCTURES OF HUMAN HSP90ALPHA COMPLEXED WITH DIHYDROXYPHENYLPYRAZOLES
1YC3A:10-223CRYSTAL STRUCTURE OF HUMAN HSP90ALPHA COMPLEXED WITH DIHYDROXYPHENYLPYRAZOLES
1YC4A:15-224CRYSTAL STRUCTURE OF HUMAN HSP90ALPHA COMPLEXED WITH DIHYDROXYPHENYLPYRAZOLES
1YERA:17-223HUMAN HSP90 GELDANAMYCIN-BINDING DOMAIN, "CLOSED" CONFORMATION
1YESA:11-223HUMAN HSP90 GELDANAMYCIN-BINDING DOMAIN, "OPEN" CONFORMATION
1YETA:11-223GELDANAMYCIN BOUND TO THE HSP90 GELDANAMYCIN-BINDING DOMAIN
1ZXMA:38-276; B:38-276HUMAN TOPO IIA ATPASE/AMP-PNP
1ZXNC:37-287; A:37-276; B:37-276; D:37-287HUMAN DNA TOPOISOMERASE IIA ATPASE/ADP
2BSMA:16-224NOVEL, POTENT SMALL MOLECULE INHIBITORS OF THE MOLECULAR CHAPERONE HSP90 DISCOVERED THROUGH STRUCTURE-BASED DESIGN
2BT0A:16-224; B:16-224NOVEL, POTENT SMALL MOLECULE INHIBITORS OF THE MOLECULAR CHAPERONE HSP90 DISCOVERED THROUGH STRUCTURE-BASED DESIGN
2BTZA:179-362CRYSTAL STRUCTURES OF HUMAN PYRUVATE DEHYDROGENASE KINASE 2 CONTAINING PHYSIOLOGICAL AND SYNTHETIC LIGANDS
2BU2A:179-362CRYSTAL STRUCTURES OF HUMAN PYRUVATE DEHYDROGENASE KINASE 2 CONTAINING PHYSIOLOGICAL AND SYNTHETIC LIGANDS
2BU5A:179-362CRYSTAL STRUCTURES OF HUMAN PYRUVATE DEHYDROGENASE KINASE 2 CONTAINING PHYSIOLOGICAL AND SYNTHETIC LIGANDS
2BU6A:179-362CRYSTAL STRUCTURES OF HUMAN PYRUVATE DEHYDROGENASE KINASE 2 CONTAINING PHYSIOLOGICAL AND SYNTHETIC LIGANDS
2BU7A:179-362CRYSTAL STRUCTURES OF HUMAN PYRUVATE DEHYDROGENASE KINASE 2 CONTAINING PHYSIOLOGICAL AND SYNTHETIC LIGANDS
2BU8A:179-362CRYSTAL STRUCTURES OF HUMAN PYRUVATE DEHYDROGENASE KINASE 2 CONTAINING PHYSIOLOGICAL AND SYNTHETIC LIGANDS
2BYHA:11-2253-(5-CHLORO-2,4-DIHYDROXYPHENYL)-PYRAZOLE-4-CARBOXAMIDES AS INHIBITORS OF THE HSP90 MOLECULAR CHAPERONE
2BYIA:11-2253-(5-CHLORO-2,4-DIHYDROXYPHENYL)-PYRAZOLE-4-CARBOXAMIDES AS INHIBITORS OF THE HSP90 MOLECULAR CHAPERONE
2BZ5A:16-225; B:16-225STRUCTURE-BASED DISCOVERY OF A NEW CLASS OF HSP90 INHIBITORS
2CCSA:16-224HUMAN HSP90 WITH 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-3-YL)-BENZENE-1,2-DIOL
2CCTA:16-224HUMAN HSP90 WITH 5-(5-CHLORO-2,4-DIHYDROXY-PHENYL)-4-PIPERAZIN-1-YL-2H-PYRAZOLE-3-CARBOXYLIC ACID ETHYLAMIDE
2CCUA:16-224HUMAN HSP90 WITH 4-CHLORO-6-(4-(4-(4-METHANESULPHONYL-BENZYL)-PIERAZIN-1-YL)-1H-PYRAZOL-3-YL)-BENZENE-1,3-DIOL
2E0AA:190-374; B:190-374CRYSTAL STRUCTURE OF HUMAN PYRUVATE DEHYDROGENASE KINASE 4 IN COMPLEX WITH AMPPNP
2FWYA:17-223STRUCTURE OF HUMAN HSP90-ALPHA BOUND TO THE POTENT WATER SOLUBLE INHIBITOR PU-H64
2FWZA:16-223STRUCTURE OF HUMAN HSP90-ALPHA BOUND TO THE POTENT WATER SOLUBLE INHIBITOR PU-H71
2H55A:16-224STRUCTURE OF HUMAN HSP90-ALPHA BOUND TO THE POTENT WATER SOLUBLE INHIBITOR PU-DZ8
2JJCA:17-223HSP90 ALPHA ATPASE DOMAIN WITH BOUND SMALL MOLECULE FRAGMENT
2K5BA:14-223HUMAN CDC37-HSP90 DOCKING MODEL BASED ON NMR
2PNRA:184-368; E:184-368; B:184-368; F:184-368CRYSTAL STRUCTURE OF THE ASYMMETRIC PDK3-L2 COMPLEX
2Q8FA:215-399STRUCTURE OF PYRUVATE DEHYDROGENASE KINASE ISOFORM 1
2Q8GA:215-399STRUCTURE OF PYRUVATE DEHYDROGENASE KINASE ISOFORM 1 IN COMPLEX WITH GLUCOSE-LOWERING DRUG AZD7545
2Q8HA:215-399STRUCTURE OF PYRUVATE DEHYDROGENASE KINASE ISOFORM 1 IN COMPLEX WITH DICHLOROACETATE (DCA)
2Q8IA:184-368PYRUVATE DEHYDROGENASE KINASE ISOFORM 3 IN COMPLEX WITH ANTITUMOR DRUG RADICICOL
2QF6A:17-223; B:17-223; C:17-223; D:17-223HSP90 COMPLEXED WITH A56322
2QFOA:17-223; B:17-223HSP90 COMPLEXED WITH A143571 AND A516383
2QG0A:17-223; B:17-223HSP90 COMPLEXED WITH A943037
2QG2A:17-223HSP90 COMPLEXED WITH A917985
2UWDA:16-224INHIBITION OF THE HSP90 MOLECULAR CHAPERONE IN VITRO AND IN VIVO BY NOVEL, SYNTHETIC, POTENT RESORCINYLIC PYRAZOLE, ISOXAZOLE AMIDE ANALOGS
2VCIA:16-2244,5 DIARYL ISOXAZOLE HSP90 CHAPERONE INHIBITORS: POTENTIAL THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER
2VCJA:16-2244,5 DIARYL ISOXAZOLE HSP90 CHAPERONE INHIBITORS: POTENTIAL THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER
2WI1A:16-224ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE HSP90 CHAPERONE
2WI2A:16-224; B:16-224ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE HSP90 CHAPERONE
2WI3A:16-224ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE HSP90 CHAPERONE
2WI4A:16-224ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE HSP90 CHAPERONE
2WI5A:16-224ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE HSP90 CHAPERONE
2WI6A:16-224ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE HSP90 CHAPERONE
2WI7A:16-224ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE HSP90 CHAPERONE
2XABA:16-224; B:16-224STRUCTURE OF HSP90 WITH AN INHIBITOR BOUND
2XDKA:11-225STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND
2XDLA:17-224STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND
2XDSA:17-223STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND
2XDUA:17-224STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND
2XDXA:11-224STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND
2XHRA:17-224STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND
2XHTA:12-224STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND
2XHXA:11-224STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND
2XJGA:11-223STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND
2XJJA:17-224; B:17-224STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND
2XJXA:11-231STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND
2XK2A:12-224STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND
2ZDXA:190-374; B:190-374INHIBITOR-BOUND STRUCTURES OF HUMAN PYRUVATE DEHYDROGENASE KINASE 4
2ZDYA:190-374; B:190-374INHIBITOR-BOUND STRUCTURES OF HUMAN PYRUVATE DEHYDROGENASE KINASE 4
2ZKJB:190-374; A:190-374CRYSTAL STRUCTURE OF HUMAN PDK4-ADP COMPLEX
3BM9A:17-223DISCOVERY OF BENZISOXAZOLES AS POTENT INHIBITORS OF CHAPERONE HSP90
3BMYA:11-223DISCOVERY OF BENZISOXAZOLES AS POTENT INHIBITORS OF CHAPERONE HSP90
3FT5A:16-223STRUCTURE OF HSP90 BOUND WITH A NOVEL FRAGMENT
3FT8A:16-223STRUCTURE OF HSP90 BOUND WITH A NOVAL FRAGMENT.
3HEKA:10-229; B:9-231HSP90 N-TERMINAL DOMAIN IN COMPLEX WITH 1-{4-[(2R)-1-(5-CHLORO-2,4-DIHYDROXYBENZOYL)PYRROLIDIN-2-YL]BENZYL}-3,3-DIFLUOROPYRROLIDINIUM
3HHUA:16-223; B:16-224HUMAN HEAT-SHOCK PROTEIN 90 (HSP90) IN COMPLEX WITH {4-[3-(2,4-DIHYDROXY-5-ISOPROPYL-PHENYL)-5-THIOXO- 1,5-DIHYDRO-[1,2,4]TRIAZOL-4-YL]-BENZYL}-CARBAMIC ACID ETHYL ESTER {ZK 2819}
3K97A:16-225HSP90 N-TERMINAL DOMAIN IN COMPLEX WITH 4-CHLORO-6-{[(2R)-2-(2-METHYLPHENYL)PYRROLIDIN-1-YL]CARBONYL}BENZENE-1,3-DIOL
3K98A:9-227; B:9-229HSP90 N-TERMINAL DOMAIN IN COMPLEX WITH (1R)-2-(5-CHLORO-2, 4-DIHYDROXYBENZOYL)-N-ETHYLISOINDOLINE-1-CARBOXAMIDE
3K99B:11-226; C:11-226; D:10-226; A:9-226HSP90 N-TERMINAL DOMAIN IN COMPLEX WITH 4-(1,3-DIHYDRO-2H-ISOINDOL-2-YLCARBONYL)BENZENE-1,3-DIOL
(-)
Leishmania major strain friedlin. Organism_taxid: 347515. Strain: friedlin. (1)
3H80A:-5-208CRYSTAL STRUCTURE OF THE AMINO-TERMINAL DOMAIN OF HSP90 FROM LEISHMANIA MAJOR, LMJF33.0312:M1-K213
(-)
Myxococcus xanthus dk 1622. Organism_taxid: 246197. Strain: dk 1622. (1)
3CWVA:8-205; B:10-205CRYSTAL STRUCTURE OF B-SUBUNIT OF THE DNA GYRASE FROM MYXOCOCCUS XANTHUS
(-)
Norway rat (Rattus norvegicus) (3)
1JM6B:1181-1361; A:1181-1362PYRUVATE DEHYDROGENASE KINASE, ISOZYME 2, CONTAINING ADP
3CRKA:187-370; B:187-370CRYSTAL STRUCTURE OF THE PDHK2-L2 COMPLEX.
3CRLA:187-370; B:187-370CRYSTAL STRUCTURE OF THE PDHK2-L2 COMPLEX.
(-)
Plasmodium falciparum 3d7. Organism_taxid: 36329. Strain: 3d7. (1)
3IEDA:89-337CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF PLASMODIUM FALCIPARUM HSP90 (PF14_0417) IN COMPLEX WITH AMPPN
(-)
Rat (Rattus norvegicus) (3)
1GJVA:194-377BRANCHED-CHAIN ALPHA-KETOACID DEHYDROGENASE KINASE (BCK) COMPLXED WITH ATP-GAMMA-S
1GKXA:194-377BRANCHED-CHAIN ALPHA-KETOACID DEHYDROGENASE KINASE (BCK)
1GKZA:194-377BRANCHED-CHAIN ALPHA-KETOACID DEHYDROGENASE KINASE (BCK) COMPLXED WITH ADP
(-)
Staphylococcus aureus. Organism_taxid: 1280. (2)
3G75A:24-230; B:24-230CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS GYRASE B CO-COMPLEXED WITH 4-METHYL-5-[3-(METHYLSULFANYL)-1H-PYRAZOL-5-YL]-2-THIOPHEN-2-YL-1,3-THIAZOLE INHIBITOR
3G7BA:24-230; B:24-230STAPHYLOCOCCUS AUREUS GYRASE B CO-COMPLEX WITH METHYL ({5-[4-(4-HYDROXYPIPERIDIN-1-YL)-2-PHENYL-1,3-THIAZOL-5-YL]-1H-PYRAZOL-3-YL}METHYL)CARBAMATE INHIBITOR
(-)
Sulfolobus shibatae. Organism_taxid: 2286. (7)
1MU5A:10-220STRUCTURE OF TOPOISOMERASE SUBUNIT
1MX0F:10-220; B:10-220; C:10-220; D:10-220; A:10-220; E:10-220STRUCTURE OF TOPOISOMERASE SUBUNIT
1Z59A:9-220TOPOISOMERASE VI-B, ADP-BOUND MONOMER FORM
1Z5AA:4-220; B:4-220TOPOISOMERASE VI-B, ADP-BOUND DIMER FORM
1Z5BA:4-220; B:4-220TOPOISOMERASE VI-B, ADP ALF4- BOUND DIMER FORM
1Z5CA:4-220; B:4-220TOPOISOMERASE VI-B, ADP PI BOUND DIMER FORM
2HKJA:10-220TOPOISOMERASE VI-B BOUND TO RADICICOL
(-)
Thermotoga maritima. Organism_taxid: 2336. (1)
1B3QB:355-539; A:355-539CRYSTAL STRUCTURE OF CHEA-289, A SIGNAL TRANSDUCING HISTIDINE KINASE
(-)
Thermotoga maritima. Organism_taxid: 2336. (7)
1I58A:352-540; B:354-540STRUCTURE OF THE HISTIDINE KINASE CHEA ATP-BINDING DOMAIN IN COMPLEX WITH ATP ANALOG ADPCP AND MAGNESIUM
1I59B:353-540; A:353-540STRUCTURE OF THE HISTIDINE KINASE CHEA ATP-BINDING DOMAIN IN COMPLEX WITH ADPNP AND MAGENSIUM
1I5AA:352-540; B:353-540STRUCTURE OF CHEA DOMAIN P4 IN COMPLEX WITH ADPCP AND MANGANESE
1I5BA:352-540; B:353-540STRUCTURE OF CHEA DOMAIN P4 IN COMPLEX WITH ADPNP AND MANGANESE
1I5CA:353-540; B:354-540STRUCTURE OF CHEA DOMAIN P4 IN COMPLEX WITH ADP
1I5DA:350-539STRUCTURE OF CHEA DOMAIN P4 IN COMPLEX WITH TNP-ATP
2CH4A:352-540COMPLEX BETWEEN BACTERIAL CHEMOTAXIS HISTIDINE KINASE CHEA DOMAINS P4 AND P5 AND RECEPTOR-ADAPTOR PROTEIN CHEW
(-)
Thermus thermophilus. Organism_taxid: 274. (1)
1KIJA:12-219; B:12-219CRYSTAL STRUCTURE OF THE 43K ATPASE DOMAIN OF THERMUS THERMOPHILUS GYRASE B IN COMPLEX WITH NOVOBIOCIN
(-)
Homologous Superfamily: [code=3.30.565.30, no name defined] (3)
(-)
Bacillus subtilis. Organism_taxid: 1423. (2)
1IXMB:272-390; A:72-191CRYSTAL STRUCTURE OF SPOOB FROM BACILLUS SUBTILIS
2FTKA:72-192; B:272-392; C:472-592; D:672-792BERYLLOFLOURIDE SPO0F COMPLEX WITH SPO0B
(-)
Bacillus subtilis. Organism_taxid: 1423. Expression_system_vector_type: plasmid. (1)
1F51A:72-190; B:272-390; C:472-590; D:672-790A TRANSIENT INTERACTION BETWEEN TWO PHOSPHORELAY PROTEINS TRAPPED IN A CRYSTAL LATTICE REVEALS THE MECHANISM OF MOLECULAR RECOGNITION AND PHOSPHOTRANSFER IN SINGAL TRANSDUCTION
(-)
Homologous Superfamily: Fervidobacterium nodosum Rt17-B1 like (1)
(-)
Fervidobacterium nodosum rt17-b1. Organism_taxid: 381764. Strain: rt17-b1 / dsm 5306. (1)
3CYGA:36-154; B:39-154CRYSTAL STRUCTURE OF AN UNCHARACTERIZED PROTEIN FROM FERVIDOBACTERIUM NODOSUM RT17-B1